Managing Risks to Improve Health Outcomes: How to Move Population Health Forward in an Era of Uncertainty

At the Canadian Association for Population Therapeutics (CAPT) Annual Conference, Sumeet Singh, Senior Director, EVERSANA, delivered a presentation on pharmacoeconomic analysis and outcome-based agreements and what they mean for Canadian private payers.

Watch his session below for answers to the following questions:

• Are pharmacoeconomic analyses relevant for private payers?
• Should pharmacoeconomic analyses for private payers differ from those for HTA/public payers?
• Should a societal or health system perspective be considered at all by private payers?